Eliem Therapeutics Price on September 26, 2024
| ELYMDelisted Stock | USD 3.04 0.04 1.30% |
If you're considering investing in Eliem Stock, it is important to understand the factors that can impact its price. As of today, the current price of Eliem Therapeutics stands at 3.04, as last reported on the 1st of December, with the highest price reaching 3.18 and the lowest price hitting 2.98 during the day. Eliem Therapeutics secures Sharpe Ratio (or Efficiency) of -0.24, which denotes the company had a -0.24% return per unit of risk over the last 3 months. Eliem Therapeutics exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Eliem Therapeutics' Mean Deviation of 3.87, standard deviation of 5.36, and Variance of 28.74 to check the risk estimate we provide.
Eliem Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Eliem |
Sharpe Ratio = -0.2418
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ELYM |
Estimated Market Risk
| 4.86 actual daily | 43 57% of assets are more volatile |
Expected Return
| -1.18 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.24 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Eliem Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Eliem Therapeutics by adding Eliem Therapeutics to a well-diversified portfolio.
Related Headline
Shattuck Labs Headline on 26th of September 2024
Disposition of 2290 shares by Abhinav Shukla of Shattuck Lab... by Abhinav Shukla
Filed transaction by Shattuck Labs Officer Chief Technical Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3
Eliem Therapeutics Valuation on September 26, 2024
It is possible to determine the worth of Eliem Therapeutics on a given historical date. On September 26, 2024 Eliem was worth 5.55 at the beginning of the trading date compared to the closed value of 5.0. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Eliem Therapeutics stock. Still, in general, we apply an absolute valuation method to find Eliem Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Eliem Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Eliem Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 8.01 | 8.15 | 5.33 | 5.50 | 5,349,433 | |
09/26/2024 | 5.55 | 5.63 | 4.84 | 5.00 | 1,331,046 |
| 5.00 | 5.10 | 4.75 | 4.98 | 585,131 |
| Backtest Eliem Therapeutics | | | Eliem Therapeutics History | | | Eliem Therapeutics Valuation | Previous | Next |
Eliem Therapeutics Trading Date Momentum on September 26, 2024
| On September 27 2024 Eliem Therapeutics was traded for 4.98 at the closing time. The top price for the day was 5.10 and the lowest listed price was 4.75 . The trading volume for the day was 585.1 K. The trading history from September 27, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 0.40% . The overall trading delta against the current closing price is 3.80% . |
Eliem Therapeutics Fundamentals Correlations and Trends
By evaluating Eliem Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Eliem Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Eliem financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Eliem Therapeutics Stock history
Eliem Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Eliem is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Eliem Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Eliem Therapeutics stock prices may prove useful in developing a viable investing in Eliem Therapeutics
Eliem Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in chronic pain, neuropsychiatry, epilepsy, and other disorders of the peripheral and central nervous systems. Eliem Therapeutics, Inc. was incorporated in 2018 and is headquartered in Redmond, Washington. Eliem Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 41 people.
Eliem Therapeutics Stock Technical Analysis
Eliem Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
Price Boundaries
Eliem Therapeutics Period Price Range
Low | December 1, 2024
| High |
0.00 | 0.00 |
Eliem Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Eliem Therapeutics December 1, 2024 Market Strength
Market strength indicators help investors to evaluate how Eliem Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Eliem Therapeutics shares will generate the highest return on investment. By undertsting and applying Eliem Therapeutics stock market strength indicators, traders can identify Eliem Therapeutics entry and exit signals to maximize returns
Eliem Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Eliem Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Eliem Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Eliem to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.12) | |||
| Jensen Alpha | (0.72) | |||
| Total Risk Alpha | (1.77) | |||
| Treynor Ratio | 0.6935 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Eliem Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Consideration for investing in Eliem Stock
If you are still planning to invest in Eliem Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Eliem Therapeutics' history and understand the potential risks before investing.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |